Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Public Library of Science 2019

Gelijkaardige items

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
door: Wiriya Mahikul, et al.
Gepubliceerd in: (2019-01-01)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
door: Mahikul, W, et al.
Gepubliceerd in: (2019)

A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand
door: Mahikul, W, et al.
Gepubliceerd in: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
door: Wiriya Mahikul, et al.
Gepubliceerd in: (2019-05-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
door: Ralph A. Tripp, et al.
Gepubliceerd in: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
door: Leonard R. Krilov, et al.
Gepubliceerd in: (2022-09-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
door: Kinyanjui, T, et al.
Gepubliceerd in: (2020)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
door: White, L, et al.
Gepubliceerd in: (2005)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
door: Jackelyn Murray, et al.
Gepubliceerd in: (2022-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
door: White, L, et al.
Gepubliceerd in: (2005)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
door: Dvir Gatt, et al.
Gepubliceerd in: (2023-01-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
door: Pan-Ngum, W, et al.
Gepubliceerd in: (2016)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
door: Timothy Kinyanjui, et al.
Gepubliceerd in: (2020-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
door: Gengxin Zhang, et al.
Gepubliceerd in: (2024-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
door: Shira Hirsh, et al.
Gepubliceerd in: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
door: Mohamad El Labban, et al.
Gepubliceerd in: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
door: Mark R. Ackermann, et al.
Gepubliceerd in: (2012-10-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
door: Samuel PC Brand, et al.
Gepubliceerd in: (2020-03-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
door: Rachel J Derscheid, et al.
Gepubliceerd in: (2013-01-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
door: Antepowicz, A, et al.
Gepubliceerd in: (2018)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
door: Tatyana M. Khomenko, et al.
Gepubliceerd in: (2021-12-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
door: Selir M. Straliotto, et al.
Gepubliceerd in: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
door: Selir M. Straliotto, et al.
Gepubliceerd in: (1994-03-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
door: Envera Lekic, et al.
Gepubliceerd in: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
door: Andrea Gastaldi, et al.
Gepubliceerd in: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
door: Harrison C. Bergeron, et al.
Gepubliceerd in: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
door: Sameer Joshi, et al.
Gepubliceerd in: (2018-05-01)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
door: Enders Martin, et al.
Gepubliceerd in: (2005-03-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
door: Anne M Hause, et al.
Gepubliceerd in: (2017-01-01)

Model-based estimates of transmission of respiratory syncytial virus within households
door: Ivy K. Kombe, et al.
Gepubliceerd in: (2019-06-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
door: Anne M Hause, et al.
Gepubliceerd in: (2017-01-01)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
door: Patricia T. Campbell, et al.
Gepubliceerd in: (2020-11-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
door: Tatyana M. Khomenko, et al.
Gepubliceerd in: (2023-03-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
door: Drysdale, S, et al.
Gepubliceerd in: (2020)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
door: Sara Jimeno Ruiz, et al.
Gepubliceerd in: (2024-11-01)

Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
door: Anahita Poshtiban, et al.
Gepubliceerd in: (2024-08-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
door: Xiao Li, et al.
Gepubliceerd in: (2024-01-01)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
door: Asunci&oacute;n Mej&iacute;as, et al.
Gepubliceerd in: (2008-09-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
door: O'Hagan S, et al.
Gepubliceerd in: (2023-09-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
door: H K Brand, et al.
Gepubliceerd in: (2015-01-01)